Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on August 15, 2025
HeartSciences Announces Conference Participation and Investor Webinar
Southlake, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company transforming ECGs/EKGs to enable earlier detection of heart …
AIM ImmunoTech Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Continued progress across pipeline programs with focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca’s Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates promising signs of both no …
BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor
First-in-human study evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102, an orally available small molecule with potential best-in-class profile Initial development planned in obesity; BGE-102 demonstrated robust weight loss …
Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
– Live video webcast on Thursday, August 21st at 2:20 PM ET THE WOODLANDS, TX, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted …
Regen BioPharma Discusses Potential Impact of HemaXellerate on Chemotherapy Treament Market
SAN DIEGO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC ID: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate, the company’s innovative stem cell-derived therapy, which has already …
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …
Global Clinical Trial Supplies Market to Reach USD 8.18 Billion by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Innovations in supply chain management and the rise of direct-to-patient models are transforming how life sciences companies execute global clinical trials. The global clinical trial supplies market, …
Intelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational Efficiencies
Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings Fourth quarter sequential and year-on-year revenue growth of 16%, supported by increased demand for drug …
Global Digital Pathology Market to Reach $13.7 Billion in 2029
Boston, Aug. 15, 2025 (GLOBE NEWSWIRE) -- As global demand for precision diagnostics rises, digital pathology is reshaping how clinical labs, research institutions, and healthcare systems operate. From AI-assisted image analysis to remote pathology …
Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split
FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market, announced today that …
Global Wound Care Market Set to Surpass USD 30.48 Billion by 2030 | MarketsandMarkets™
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Growing demand for advanced wound management solutions meets innovation and strategic expansion across global healthcare systems The global wound care market, valued at US$20.97 billion in 2024, stood at …
Plus Therapeutics Reports Stockholders’ Equity in Excess of $2.5 million in Compliance with Nasdaq Equity Requirements
HOUSTON, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) …
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
Patient enrollment for our ongoing Phase-3 clinical trial of SGT-610 for Gorlin Syndrome has been completed; top-line results are expected in the fourth quarter of 2026 Phase-1b proof-of-concept clinical trial of SGT-210 for Darier disease is ongoing Sol- …
Medical Tubing Market worth $18.41 billion by 2030, at a CAGR of 8.0%, says MarketsandMarkets™
Delray Beach, FL, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Medical Tubing Market is projected to reach USD 18.41 billion by 2030 from USD 12.53 billion in 2025, at a CAGR of 8.0% during the forecast period. The market for medical tubing is expanding swiftly …
To “Eat” or to “Escape”? NTHU Uncovers Olfactory Code of Fruit Fly Brain
HSINCHU, Taiwan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Director of the Brain Research Center at National Tsing Hua University (NTHU) in Taiwan, Ann-Shyn Chiang (江安世), Professor of the Institute for Systems Neuroscience, Chung-Chuan Lo (羅中泉), and …
EAACI startet globale Aufklärungskampagne zu Antibiotikaallergien auf dem EAACI-Kongress 2025 (EAACI Congress 2025)
ZÜRICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Die EAACI hat im Rahmen ihres Kongresses 2025 in Glasgow ihre Aufklärungskampagne zum Thema Antibiotikaallergien gestartet. Die Initiative ist der Beginn einer weltweiten Kampagne gegen falsche Kennzeichnung und …
L’EAACI lance une campagne mondiale de sensibilisation aux allergies aux antibiotiques lors du EAACI Congress 2025
ZURICH, 15 août 2025 (GLOBE NEWSWIRE) -- L’EAACI a lancé sa Antibiotic Allergy Awareness Campaign (Campagne de sensibilisation aux allergies aux antibiotiques) à l’occasion de son Congrès 2025 à Glasgow. Cette initiative marque le début d’un effort mondial …